The prognostic impact of CDH1 and MEG3 methylation status in multiple myeloma.
It is found that methylation was associated with poor prognosis in multiple myeloma and a trend toward reduced overall survival in the CDH1 methylated and MEG3 unmethylated patient groups suggested that CDH1 promoter hypermethylation and MEG3 promoter unmethylation status may predict poor MM prognoses.